Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study
- Resource Type
- Abstract
- Source
- In
Blood 5 November 2020 136 Supplement 1:15-16 - Subject
- Language
- ISSN
- 0006-4971